AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:20 am Sale |
2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-7,550,000 (Position Closed) |
Filing |
| 2023-02-14 09:38 am Purchase |
2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
AVORO CAPITAL ADVISORS LLC | 7,550,000 7.600% |
750,000 (+11.03%) |
Filing |
| 2021-02-12 08:04 am Purchase |
2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
AVORO CAPITAL ADVISORS LLC | 6,800,000 9.900% |
6,800,000 (New Position) |
Filing |